ADLN - PERPUSTAKAAN UNIVERSITAS AIRLANGGA

DAFTAR PUSTAKA

Abdou, H., Hanna, S., Muhammad, N., 2000. Dissolution, In: Alfonso R
Gennaro (Ed.), Remington: The Science anda Practice of
Pharmacy, 20th ed., Philadelphia: Lippincott Williams & Wilkins. p.
672-687.

Aitipamula, S., Chow, PS., Tan, RBH. 2009. Dimorphs of a 1:1 cocrystal of
ethenzamide and saccharin : solid-state grinding methods result in
metastable polymorph. Cryst Eng Comm. 11: p. 889-895.

Alhalaweh, A. 2012. Pharmaceutical Cocrystal (Formation Mechanisms,

Solubility Behaviour and Solid-State Properties). Thesis., Lulea
University of Technology. ISSN: 1402-1544. p. 15-36.

Almarsson, O., Zaworotko, MJ. 2004. Crystal engineering of the

composition of pharmaceutical phases. Do pharmaceutical co-
crystals represent a new path to improved medicines. Chem
Commun : p. 1889-1896.

Ansel, H.C., Popovich, N.G., Allen, L.V., 2011. Pharmaceutical Dosage

Form and Drug Delivery System, 9th ed. Malvern : Williams &
Wilkins. p.104.

Al-Taani, B., Salem, M.S., Al Taani, S. 2009. Influence of Polyvinyl

Pyrrolidone Addition during Crystallization on the Physicochemical
Properties of Mefenamic Acid Crystals. JJPharmScie. Vol.2 p. 86-
98.

82

SKRIPSI PENINGKATAN LAJU DISOLUSI

RIKYAWAN
... KUSWANDIONO
 ADLN - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
83

Basavoju, S., Bostrom, D., Velaga, S.P., 2006. Pharmaceutical Cocrystal

and Salts of Norfloxacin. Cryst. Growth Vol 6: p. 2699-2708.

Basavoju, S., Bostrom, D., Velaga, S.P., 2007. Indomethacin-Saccharin

Cocrystal:Design, Synthesis and Preliminary Pharmaceutical
Characterization. Pharm. Res., Vol 25 No 3. p. 530-41.

Bis, J. A., Zaworotko, M. J., Vishweshwar, P., McMahon, J.A. 2005.,

Pharmaceutical co-crystals. Cryst. Growth & Des, 5, p. 1169.

Brunton, L.L., Lazo, J.S., Parker, K.L. 2006. Goodman & Gilman’s the
Pharmacological Basis of Therapeutics 11th Ed. The McGraw-Hill
Companies. Inc. chapter. 26.

Budavari., Susan., Maryadele, J.O’Neil., Ann Smith., Patricia

E.Heckelmen., Joanne, F.Kinneary. 2001. The Merck Index, New
Jersey : Merck Research Laboratories Division Of Merck &CO., Inc,
p. 473-474.

Chandramouli, Y., Gandhimathi, R, Yasmeen, B. R., Vikram, A., Mahitha,

B dan Imroz, S.M. 2012. Review On Cocrystal As An Approach
With Newer Implications in Pharmaceutical Field. IJMCA 2(2) p.
91-100.

Chaudhary, A., Nagaich, U., Gulati, N., Sharma, V.K., Khosa, R.L., 2012.
Enhancement of solubilization and bioavailability of poorly soluble
drugs by physical and chemical modifications : A recent review.,
JAPTR., p. 32-67.

SKRIPSI PENINGKATAN LAJU DISOLUSI

RIKYAWAN
... KUSWANDIONO
 ADLN - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
84

Cheney, Miranda L., Shan Ning, Healey, E.R., Hanna, M., Wojtas, L.,
Zaworotko, M.J., Sava, V., Song, S., Sanchez-Ramoz, J.R. 2009.
Effect of Crystal Form in Solubility and Pharmacokinetics: A Crystal
Engineering Case Study of Lamotrigine. Cryst. Growth & Des, 2010,
Vol 10, p. 394-405.

Departemen Kesehatan Republik Indonesia., 1995. Farmakope Indonesia.

Edisi ke 4. Jakarta : Departemen Kesehatan Republik Indonesia p.
43, p. 748.

Durgashanskar, P., Ashish, P., Anjali, P. 2012. A Review on Co-Crystal.,

JSRP. p.

Erizal Zaini, et al. 2010. Cocrystalline phase transformation of binary

mixture of trimethoprim and sulfamethoxazole by slurry technique.
AJPCR. 3(4). p 26-29..

Fabian, L., Hamill, N., Eccles, K.S., Moynihan, H.A., Maguire, A.R.,
McCausland, L., Lawrence, S.E. 2011. Cocrystals of Fenamic Acids
with Nicotinamide. Cryst. Growth & Des. 11 (8):3522-3528 p. 1-24.

Food and Drug Administration., 2000. Waiver of In Vivo Bioavailability

and Bioequivalence Studies for Immediate-Release Solid Oral
Dosage Forms Based on a Biopharmaceutics Classification Sytem :
U.S Departement of health and Human Service. p. 1-13.

Fotaki, N., Tomaszewska, I., Karki, S., Shur, J., Price, R. 2013.
Pharmaceutical characterization and evaluation of cocrystals:
Importance of in vitro dissolution conditions and type of conformer.
IJPharm. p.380-388.

SKRIPSI PENINGKATAN LAJU DISOLUSI

RIKYAWAN
... KUSWANDIONO
 ADLN - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
85

Gao, Y., Gao, J., Liu, Z., Kan, H., Zu, H., Sun, W., Zhang, J., Qian,S.
2012., Coformer selection based on degradation pathway of drugs : a
case study of adefovir dipivoxil-saccharin and adefovir dipivoxil-
nicotinamid cocrystals., Int J Pharm. 15;438 (1-2): p. 327-35.

Goldberg, A.H., Gibaldi., Kanig, J.L. 1996. Increasing dissolution rates and
gastrointestinal absorption of drug via soil solution and eutectic
mixture, experimental evolution of eutectic mixture; urea
acetaminophen system. J.Pharm Sci. 55: p. 482-487.

Horst, J.; Cain, P., Deij, M.A. 2009. Discovering new co-crystals .Cryst.
Growth Vol. 9: p. 1531-1537.

Jackson, J.V., Moss, M.S., Widdop, B., Moffiat, A.C. 1986. Clarke’s
Isolation & Identification of Drugs, 2nded, Pharmaceutical Press,
p.727.

Jasud, S., Warad, S., Rahul, S., Jagdale, G., Zinjad, S. 2013., Cocrystal: A
Novel Approach for Bioavailability Enhancement., WJPPS. Vol.2
Issue 6, p. 4682-4697.

Jatwani, S., Rana, A.C., Singh, G., Aggarwal, G. 2011. An Overview on

Solubility Enhancement Techniques For Poorly Soluble Drugs and
Solid Dispersion As an Eminent Strategic Approach. IJPSR. Vol.3
Issue 4. p. 942-956.

Jayasankar, A., Somwangthanaroj, A., Shao, ZJ., Rodrıguez-Hornedo, N.

2006. Co-crystal formation during cogrinding and storage is
mediated by amorphous phase. Pharm Res. 23: p. 2381-2392.

SKRIPSI PENINGKATAN LAJU DISOLUSI

RIKYAWAN
... KUSWANDIONO
 ADLN - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
86

Jayasankar, A., Good, DJ., Rodrigues-Hornedo, N. 2007. Mechanism by

which moisture generates cocrystal. Mol Pharm. 4: p. 360-372

Jung, J., Perrut, M. 2001. Particle design using supercritical fluids:

Literature and patent survey. Journal Supercritical Fluids, 20, p.
179-219.

Keshavarao, K.P., Mudit, D., Selvam, P. 2011. Improvement of Solubility

And Dissolution Rate of Mefenamic Acid By Solid Dispersions in
PEG 4000., IRJP., p. 207-210.

Keshavarao, K.P., Mudit, D., Bhardwaj, Y., Selvam, P. 2011. Enhancing

Solubility and Dissolution of Mefenamic Acid by Freeze Drying
Using β-Cyclodextrin., IRJP. p. 146-150.

Khan, K.A., 1975. The Concept of Dissolution Efficiency. J. Pharm.

Phamac., 27(1). p. 48-9.

Kothur, R.R., Swetha, A.S., Bondili, N.P. 2012. An Outline of Crystal

Engineering of Pharmaceutical Co-Crystals and Aplications : A
Review. IJPRD vol 4 (08): p. 84-92.

Mc Evoy, G.K.(Ed.). 2002. AHFS Drug Information, book 4, USA :

American Society of Health System Pharmacists, p. 2005-2008.

Mcnamara, D.P., S.L Childs, J. Giordano, A larriccio, J.Cassidy, M.S Shet,

R.Mannion, E. O’Donnel, and A.Park., 2006. Use of a glutaric acid
cocrystal to improve oral bioavaibility of a low solubility API.
Pharm res. 23: p. 1888-1897.

SKRIPSI PENINGKATAN LAJU DISOLUSI

RIKYAWAN
... KUSWANDIONO
 ADLN - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
87

Mirza, S., Miroshnyk, I., Heinamaki, J., Yliruusi, J., 2008. Co-crystal: an
Emerging Approach for Enhancing Properties of Pharmaceutival
Solids. Dosis Vol 24 No.2: p. 90-95.

Mohanachandran, P.S., Sindhumol, P.G., Kiran, T.S., 2010. Enhancement

of Solubility and Dissolution Rate : An Overview., Pharmacie
Globale (IJCP)., p. 1-10.

Mudit, D., Ashwini, G.K., Parthasarthi, K.K. 2012. Enhancing The

Dissolution Of Polymorphs I and Polymorphs II of Mefenamic Acid
By Spray Drying., Turk J.Pharm Sci. 9(1). p. 13-26.

Mundhe, A.V., Kumar, F.N., Radheshyam, B.K. 2013. Cocrystalization :

An Alternative Approach For Solid Modification. JDDT. 3(4). p.
166-172.

Nagabhushanam, MV., Sudha Rani, A. 2010. Dissolution Enhancement of

Mefenamic Acid Using Solid Dispersions In Crospovidone., IJPPS.
p. 16-19.

Nagabhushanam, MV., Rao Prasada, V., Prabhakar CH. 2011. Formulation

and Evaluation of HP-β-Cyclodextrin Complexes of Mefenamic
Acid Tablets., IJPT. p. 2669-2679.

Nehm S.J., Rodríguez-Spong B., Rodríguez-Hornedo N. 2006. Phase

solubility diagrams of co-crystals are explained by solubility product
and solution complexation. Cryst Growth Vol.6: p. 592-600.

SKRIPSI PENINGKATAN LAJU DISOLUSI

RIKYAWAN
... KUSWANDIONO
 ADLN - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
88

Padrela, L., Rodrigues, MA., Velaga, SP., Matos, HA., de Azevedo, EG.
2009. Formation of indomethacin-saccharin cocrystals using
supercritical fluid technology. Eur J Pharm Sci 38 : p. 9-17.

Patil, B.P., Udupi, RH., Gupta, VRM., Prasad, B S G. 2010. Development

of dissolution medium for poorly water soluble drug mefenamic acid.
RJPBCS 1 (4). p. 544-549.

Qiao, N., Li, M H., Schlindwein, W., Malek, N., Davies, A., Trappitt, G.
2011. Pharmaceutical cocrystals : An overview. Int. J. Pharm. 419 :
p. 1-11.

Rahman, Z., Agarabi, C., Zidan, Ahmed S., Khan, S.R dan Khan, Mansoor
A. 2011. Physico-mechanical and stability Evaluation of
Carbamazepine Cocrystal with Nicotinamide. AAPS PharmSciTech,
12(2), p. 693-704.

Rahman, Z., Samy, R., Saveed, V.A., Khan, M.A. 2012., Physicochemical
and mechanical properties of carbamazepine cocrystals with
saccharin., Pharm Dev Technol., 17(4): p. 457-65.

Rao, P., Nagabhushanam, M.V. 2011. Enhancement Of Dissolution Profile

of Mefenamic Acid By Solid Dispersion Technique., IJRPC. p.
1127-1134.

Rao, P.CH., Nagabhushanama, MV., Prabhakar, CH. 2011. Enhancement of

Dissolution Rate of Poorly Soluble Drug Mefenamic Acid by Solid
Dispersion., RJPBCS. p. 1025-1035.

Rohrs, B.R., 2001. Dissolution Method Development for Poorly Soluble

Compound. Dissolution Technologies. 8(3), p.1-5.

SKRIPSI PENINGKATAN LAJU DISOLUSI

RIKYAWAN
... KUSWANDIONO
 ADLN - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
89

Rowe, C.R., Sheskey, J.P., and Weller, P.J. 2003. Handbook of

Pharmcaeutical Excipients, Ed. 4th, London : Pharmaceutical Press,
p. 529-534.

Sambaasiva Rao, K.R.S., Nagabhushanam, MV., Chowdary, K.P.R. 2011 In

vitro dissolution studies on solid dispersions of mefenamic acid.,
Pharm res., Vol 73, p. 243-247.

Savjani, J.K., Pathak, C.D., Savjani, K.T., Gajjar, A.K. 2013. Cocrystal
Formation Of Paracetamol With Indomethacin And Mefenamic Acid
An Efficient Approach To Enhance Solubility. IJPPS. Vol.5, Issue
4. p. 414-419.

Schultheiss N, Newman A. 2009. Pharmaceutical co-crystals and their

physicochemical properties. Cryst Growth. Vol.9 : p. 2950–2967.

Sekhon, B. S. 2012. Drug-drug co-crystals. DARU J. Pharm Sci , 20: p.

45

Sekhon, B. S. 2012. Nutraceutical Cocrystals: An overview. RGUHS J

Pharm Sci, 2(2). p. 16-25.

Setyawan, D., Sari, R., Yusuf, H., Primaharinastiti, R. 2013., Preparation

and Characterizationof Artesunate – Nicotinamide Cocrystal by
Solvent Evaporation and Slurry Method., Asian J Pharm.Clin Res.
Vol.7. p. 62-65.

Shariff, JS., Saleem, S., Kumar, ANP., Kumar, BA., Madhusudhan, P.

2013. Formulation And Evaluation of Mefenamic Acid Solid
Dispersions Using PEG 4000., IRJP. p. 155-159.

SKRIPSI PENINGKATAN LAJU DISOLUSI

RIKYAWAN
... KUSWANDIONO
 ADLN - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
90

Shiraki, K., Takata, N., Takano, R., Hayashi, Y., Terada, K. 2008.
Dissolution improvement and the mechanism of the improvement
from cocrystallization of poorly water-soluble compounds. Pharm
Res. 25 : p. 2581-2592.

Sinko, P. 2006. Physical Pharmacy. 5th ed. Baltimore : Lippincott Williams

& Wilkins. p. 300-317.

Siregar, C.J.P. dan Wikarsa, S. 2002. Teknologi Farmasi Sediaan Tablet

Dasar– Dasar Praktis. Jakarta : EGC p. 54.

Siswandono & Soekardjo, Bambang. 2000. Prinsip-Prinsip Rancangan

Obat, Cetakan kedua. Surabaya : Airlangga University Press. p. 300.

Stahly GP. 2009. A survey of co crystals reported prior to. Cryst. Growth &
Des, 9, 2009, p. 4212–4229.

Stanton, M.K., Tufekcic, S., Morgan C., Bak, A., 2009. Cryst. Growth Des.,
9, p. 1344-1352.

Sweetman, S.C. 2009. Martindale : The Complete Drug Reference. Thirty-

sixth edition. London : Pharmaceutical Press. p. 80.

Takata, N., Takano, R., Uekusa, H., Hayashi, Y., Terada, K. 2010. A
spironolactone-saccharin 1:1 cocrystal hemihydrate. Cryst. Growth.
10 : p. 2116-2122.

Thakuria, R., Delori, A., Jones, W., Lipert, M.P., Roy, L., Hornedo, NR.
2013. Pharmaceutical cocrystals and poorly soluble drugs. IJPharm.
453: p. 101– 125.

SKRIPSI PENINGKATAN LAJU DISOLUSI

RIKYAWAN
... KUSWANDIONO
 ADLN - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
91

Tiekink, E.R.T. dan Vittal, J.J. 2006. Crystal Engineering of Pharmaceutical

Cocrystals. In: Vishweshwar, P., McMahon, J.A., dan Zawarotko,
M.J. Frontiers In Crystal Engineering. West Sussex : John Wiley &
Sons Ltd., p. 25-45.

United State Pharmacopoeial Convention, 2007. USP 30 NF 25, Rockville.

MD The United States Pharmacopoeial Convention, Inc. p. 1202, p.
2560.

Velaga, SP., Basavoju, S Bostrom D. 2008. Norfloxacin saccharinate-

saccharin dihydrate cocrystal – A new pharmaceutical cocrystal with
an organic counter ion. J Mol Struct. 889: p. 150-153.

Vishweshwar, P., Nangia, A., Lynch, VM. 2003. Molecular complexes of

homologous alkanedicarboxylic acids with isonicotinamide: X-ray
crystal structures, hydrogen bond synthons, and melting point
alternation. Cryst. Growth Des. 7 : p. 1007-1026.

Vishweshwar, P., McMahon, JA., Bis, JA., Zaworotko, MJ. 2006.

Pharmaceutical co-crystals., J Pharm Sci, 95, p. 499-516.

Walsh, RDB., Bradner, MW., Fleischman S., Morales, LA., Moulton, B,

Rodriguez-Hornedo, N., Zaworotko, MJ., 2003 Crystal engineering
of the composition of pharmaceutical phases. Chem Commun. p.
186-187.

SKRIPSI PENINGKATAN LAJU DISOLUSI

RIKYAWAN
... KUSWANDIONO
 ADLN - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
92

Williams, H.D., Trevaskis, N.L., Charman, S.A., Shanker, R.M., Charman,

W.N., Poulon, C.W., Porter, C.J.H., 2013. Strategies to Address Low
Drug Solubility in Discovery and Development, Pharmacological
Reviews, Vol 65, No.2. p. 315-499.

Yu Lx., Amidon, GL., Polli, JE., Zhao, H., Mehta, MU., Conner, DP., Shah,
VP., Lesko, LJ., Chen, ML., Lee, VH., Hussain, AS. 2002. A Bio
pharmaceutics classification system: the scientific basis for
Biowaiver Extension. Pharm. Res., Vol 19: p. 921-925.

Zhang, J., Qian, S., Gao, Y., Gao, J., Liu, Z., Kan, H., Zu, H., Sun, W.
2012. Coformer selection based on degradation pathway of drugs: A
case study of adefovir dipivoxil-saccharin and adefovir dipivoxil-
nicotinamide cocrystals. IJPharm. p. 327-335.

SKRIPSI PENINGKATAN LAJU DISOLUSI

RIKYAWAN
... KUSWANDIONO